Wikidata entity: Q66060504
Quantities
| P4135 | maximum age | 80 |
| P2899 | minimum age | 18 |
| P1132 | number of participants | 3300 |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P582 | end time | ... | 2024-12-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P6153 | research site | ... | Q684783 (Kanazawa University) | Kanazawa University |
| P6153 | research site | ... | Q49210 (New York University) | New York University |
| P6153 | research site | ... | Q1780816 (State University of New York at Albany) | State University of New York at Albany |
| P6153 | research site | ... | Q2471216 (Thomas Jefferson University) | Thomas Jefferson University |
| P6153 | research site | ... | Q3244340 (Juntendo University) | Juntendo University |
| P6153 | research site | ... | Q4117596 (Cleveland Clinic) | Cleveland Clinic |
| P6153 | research site | ... | Q1193547 (Tulane University of Louisiana) | Tulane University of Louisiana |
| P6153 | research site | ... | Q1209029 (Shinshu University) | Shinshu University |
| P6153 | research site | ... | Q1472663 (University of Alabama at Birmingham) | University of Alabama at Birmingham |
| P6153 | research site | ... | Q7252476 (Providence Sacred Heart Medical Center and Children's Hospital) | Providence Sacred Heart Medical Center and Children's Hospital |
| P6153 | research site | ... | Q7374471 (Royal Melbourne Hospital) | Royal Melbourne Hospital |
| P6153 | research site | ... | Q7895888 (University of Nebraska Medical Center) | University of Nebraska Medical Center |
| P6153 | research site | ... | Q11441079 (Osaka Prefectural Medical Center) | Osaka Prefectural Medical Center |
| P6153 | research site | ... | Q11469690 (Yamanashi Prefectural Central Hospital) | Yamanashi Prefectural Central Hospital |
| P6153 | research site | ... | Q11502859 (Niigata University Medical and Dental Hospital) | Niigata University Medical and Dental Hospital |
| P6153 | research site | ... | Q30258334 (UNM Los Lunas) | UNM Los Lunas |
| P6153 | research site | ... | Q30269659 (DaVita Clinical Research (United States)) | DaVita Clinical Research (United States) |
| P6153 | research site | ... | Q30269704 (Meridien Research) | Meridien Research |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270367 (Providence Clinical Research) | Providence Clinical Research |
| P6153 | research site | ... | Q50035675 (Southeast Renal Research Institute) | Southeast Renal Research Institute |
| P6153 | research site | ... | Q87473212 (Winnipeg Clinic) | Winnipeg Clinic |
| P580 | start time | ... | 2019-08-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects With Moderate to Advanced Diabetic Kidney Disease | ??? |
| P3098 | ClinicalTrials.gov ID | NCT04026165 |
Why not click here or view trends?
log id: 4264925